期刊文献+

胺碘酮对体外循环后心脏复跳及自律性的影响 被引量:3

Effect of amiodarone on restoration of sinus rhythm in patients with atrial fibrillation after cardiopulmonary bypass
下载PDF
导出
摘要 目的观察胺碘酮对体外循环术后心脏复跳及自律性的影响。方法择期二尖瓣置换的房颤患者64例随机分为三组,分别在体外循环期间静脉注射胺碘酮8mg/kg(A组),4mg/kg(B组)或等量生理盐水(C组)。观察转流时间、心脏复跳时间、自律性、临时心脏起搏及血管活性药物使用情况。结果与A、B组相比,C组的后并行时间和转流时间显著延长(P<0.01),自动复跳、复跳后窦律比例显著降低(P<0.05和P<0.01),停机后多巴胺使用量显著增加(P<0.01)。A组临时起搏器使用比例较其它两组显著增加(P<0.05)。各组复跳后窦律患者左房小于房颤患者(P<0.01),C组窦律患者左房小于其它两组(P<0.01)。结论体外循环术中心脏复跳前使用胺碘酮可以增加房颤患者心脏自动复跳的成功率,更好地维持窦性心律,稳定血流动力学,减少多巴胺用量及体外循环时间。 Objective To observe the effect of amiodarone on restoration of sinus rhythm in patients with atrial fibrillation after cardiopulmonary bypass (CPB).Methods Sixty-four patients with atrial fibrillation undergoing selective mitral valve replacement were randomly divided into three groups. They received amiodarone 8 mg/kg,4 mg/kg or the same volume of normal saline during cardiopulmonary bypass,respectively. Bypass time,cardiac recovery time,rhythm,pacemaker and dopamine usage were recorded. Results Compared with the two amiodarone groups,the posterior parallel circulation time and bypass time were significantly prolonged (P0.01),and the ratios of auto re-beat and restoration of sinus rhythm were significantly decreased,and dopamine usage was increased in the saline group (P0.05 and P0.01). The pacemaker usage ratio in the group A was higher than that of the other two groups (P0.05). The size of left atrium in patients with sinus rhythm was significantly smaller than those with atrial fibrillation (P0.01),and the size of left atrium in patients with sinus rhythm in the group C was smaller than those of the amiodarone groups (P0.01). Conclusion The use of amiodarone during CPB may increase the success rate of cardiac recovery,and maintain sinus rhythm better,and reduce dopamine usage and bypass time.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2010年第12期1034-1036,共3页 Journal of Clinical Anesthesiology
关键词 房颤 胺碘酮 体外循环 二尖瓣置换术 Atrial fibrillation Amiodarone Cardiopulmonary bypass Mitral valve replacement
  • 相关文献

参考文献9

  • 1Khanderia U, Wagner D, Walker PC, et al. Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital. Clin Cardiol,2008,31:6-10.
  • 2丁平,李莉,徐志云,邹良健,王志农,韩林,何斌.胺碘酮对风湿性心脏病瓣膜置换术后心房颤动自动复律患者围术期的窦性心律维持作用[J].中国心脏起搏与心电生理杂志,2008,22(2):122-124. 被引量:11
  • 3Zebis LR, Christensen TD, Kristiansen IS, et al. Amioda rone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg, 2008, 85:28 -32.
  • 4Zebis LR. Christensen TD, Thomsen HF, et al. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. Ann Thorac Surg, 2007, 83:1326- 1331.
  • 5赵枫,李莉,徐志云,邹良建,梅举.围术期应用胺碘酮预防治疗心脏术后心房颤动[J].中国心脏起搏与心电生理杂志,2006,20(3):210-212. 被引量:7
  • 6Letelier I.M, Udol K, Ena J, et al. Effectiveness of amioda rone for conversion of atrial fibrillation to sinus rhythm: a meta analysis. Arch Intern Med,2003,163 :777-785.
  • 7Vardas PE, Kochiadakis GE. Amiodarone for the restoration of sinus rhythm in patients with atrial fibrillation. Card Elect rophysiol Rev, 2003,7 : 297-299.
  • 8Koo EH, Park YC, Lim SH, et al. Amiodarone offsets the cardioprotective effects of ischaemic preconditioning against ischaemia/reperfusion injury. J Int Med Res, 2006, 34:140-151.
  • 9Ide T, Tsutsui H, Kinugawa S, et al. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation, 1999,100:690-692.

二级参考文献12

  • 1蒋文平.心律失常药物治疗的点评[J].中国心脏起搏与心电生理杂志,2005,19(4):243-245. 被引量:48
  • 2黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
  • 3Cohn WE, Sirois CA, Johnson RG. Atrial fibrillation after minimally invasive coronary artery bypass grafting: A retrospective, matched study[J]. J Thorac Cardiovasc Surg, 1999,117(2):298
  • 4Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery : Current trends and impact on hospital resources [ J ]. Circulation, 1996,94 : 390
  • 5Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrithmic effects of intravenous amiodarone : Results of a prospective,placebo-controlled study[J]. Am Heart J,1991,121:89
  • 6Bagshaw SM, Galbraith PD, Mitchell LB, et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardioc surgery : a metaanalysis [ J ]. Ann Thorac Surg, 2006,82 (5) : 1 927
  • 7Mathew JP, Fontes ML, Tudor IC, et al. Amulticent risk index for atrial fibrillation after cardial surgery [ J ]. JAMA,2004, 291
  • 8Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults[J]. Circulation, 1997,96:2 455
  • 9Shingawa K, Shiroshita-Takeshita A, Schram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone[J]. Circulation ,2003,107 : 1 440
  • 10Mitchell LB, Exner DV, Wyse DG, et al . Prophylactic aminodarone for the prevention of arrhythmias that begin early ( PAPABEAR ) : preliminary results[J]. Circulation, 2003, 108:2 723

共引文献16

同被引文献36

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2孟凡浩,张凤英.体外循环前并行阶段心室颤动的原因及对策[J].中国体外循环杂志,2006,4(3):165-166. 被引量:3
  • 3Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type na-triuretic peptide assay accurately diagnoses left ventricular dysfunc-tion and heart failure: amulticenter evaluation. Am Heart J,2002,144(5) :834-839.
  • 4Kaxasek D, Sinkiewicz W, Ka2ejewski J. Relationship between B-type natriuretic peptide serum level,echocardiographic TEI index andthe degree ofdiastolic dysfunction in patients with heart failure withpresmed systolic function. Arch Med Sci, 2011,7(3) :449-456.
  • 5Dokainish H, Zoghbi WA, Lakkis NM, et al. Incremental predic-tive power of B-type natriuretic peptide and tissue Doppler echocar-diography in the prognosisof patients with congestive heart failure. JAm Coll Cardiol, 2005,45(8) : 1223-1226.
  • 6Assessment of cardiac risk and the cardiology consultation: examining, imaging, optimizing, and recommending/ / Kap?lanJA, Reich DL, Lake CL, et al. Kaplan's cardiac anesthe?sia. 5th ed. Philadelphia: saunders, 2006: 283-298.
  • 7Backer DD, Biston P, DevriendtJ, et al. Comparison of do?pamine and norepinephrine in the treatment of shock. N EngJ Med, 2010,362(9): 779-790.
  • 8Smit AJ. Dopamine in heart failure and critical care. Clin Exp Hypertens, 2000, 22(3) :269-276.
  • 9Discontinuing cardiopulmonary bypass/ / KaplanJ A, Reich DL, Lake CL, et al. Kaplan's cardiac anesthesia. 5th ed. Philadelphia: Saunders, 2006: 1024-1026.
  • 10Matyal R, Skubas NJ, Shernan SK, et al. Peri operative as?sessment of diastolic dysfunction. Anesth Analg , 2011,113 (3) :449-472.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部